Clinical Trial Update: Safety and Pharmacology of Stanate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing safety and pharmacology of Stanate for hyperbilirubinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperbilirubinemia

Drugs mentioned

• Stanate

Snippet

Sponsor: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | Conditions: Hyperbilirubinemia | Phase 2 | Status: COMPLETED